Protein Synthesis Inhibitors
Start with the big picture
Bacterial ribosomes differ from human ribosomes, providing a basis for the selective action of protein synthesis inhibitors. The lesson classifies these drugs by ribosomal target: tetracyclines and aminoglycosides act at the 30S subunit, while macrolides, lincosamides, chloramphenicol, streptogramins, and oxazolidinones act at the 50S subunit. Aminoglycosides are bactericidal; most other groups are bacteriostatic. Resistance can arise through efflux pumps, changes to ribosomal targets, or enzymatic inactivation. The topic also highlights important adverse effects, including aminoglycoside nephrotoxicity, tetracycline-associated tooth discoloration, and QT prolongation with macrolides. These distinctions offer a framework for studying the classes and their clinical considerations.
What you'll learn
- Classify protein synthesis inhibitors by their 30S or 50S ribosomal target.
- Identify the major antibiotic groups associated with each ribosomal subunit.
- Distinguish aminoglycosides from most other groups by bactericidal or bacteriostatic activity.
- Recognize key resistance mechanisms and class-associated adverse effects.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
